154 related articles for article (PubMed ID: 18593994)
21. [Childhood medulloblastoma].
Yazigi-Rivard L; Masserot C; Lachenaud J; Diebold-Pressac I; Aprahamian A; Avran D; Doz F
Arch Pediatr; 2008 Dec; 15(12):1794-804. PubMed ID: 18995998
[TBL] [Abstract][Full Text] [Related]
22. [Expression of c-jun and c-fos oncogene in medulloblastoma and its clinical significance].
Li YY; Mao BY; Dong XH
Zhonghua Wai Ke Za Zhi; 2004 Feb; 42(4):213-5. PubMed ID: 15062038
[TBL] [Abstract][Full Text] [Related]
23. Microvessel density and vascular endothelial growth factor expression as predictors of childrens' survival from cerebellar medulloblastoma.
Tural S; Gercek A; Konya D; Ozgen S; Toplamoglu H; Ozek MM
J Clin Neurosci; 2009 Sep; 16(9):1199-202. PubMed ID: 19524442
[TBL] [Abstract][Full Text] [Related]
24. Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification.
Polkinghorn WR; Tarbell NJ
Nat Clin Pract Oncol; 2007 May; 4(5):295-304. PubMed ID: 17464337
[TBL] [Abstract][Full Text] [Related]
25. Medulloblastoma.
Dhall G
J Child Neurol; 2009 Nov; 24(11):1418-30. PubMed ID: 19841429
[TBL] [Abstract][Full Text] [Related]
26. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior.
Min HS; Lee YJ; Park K; Cho BK; Park SH
Acta Neuropathol; 2006 Jul; 112(1):13-20. PubMed ID: 16691420
[TBL] [Abstract][Full Text] [Related]
27. Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
Lo KC; Ma C; Bundy BN; Pomeroy SL; Eberhart CG; Cowell JK
Clin Cancer Res; 2007 Dec; 13(23):7022-8. PubMed ID: 18056178
[TBL] [Abstract][Full Text] [Related]
28. Prediction of prognosis in children with medulloblastoma by using immunohistochemical analysis and tissue microarray.
Shim KW; Joo SY; Kim SH; Choi JU; Kim DS
J Neurosurg Pediatr; 2008 Mar; 1(3):196-205. PubMed ID: 18352763
[TBL] [Abstract][Full Text] [Related]
29. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
30. Isochromosome 17q is a negative prognostic factor in poor-risk childhood medulloblastoma patients.
Pan E; Pellarin M; Holmes E; Smirnov I; Misra A; Eberhart CG; Burger PC; Biegel JA; Feuerstein BG
Clin Cancer Res; 2005 Jul; 11(13):4733-40. PubMed ID: 16000568
[TBL] [Abstract][Full Text] [Related]
31. c-myc overexpression causes anaplasia in medulloblastoma.
Stearns D; Chaudhry A; Abel TW; Burger PC; Dang CV; Eberhart CG
Cancer Res; 2006 Jan; 66(2):673-81. PubMed ID: 16423996
[TBL] [Abstract][Full Text] [Related]
32. Clinical and molecular stratification of disease risk in medulloblastoma.
Gilbertson R; Wickramasinghe C; Hernan R; Balaji V; Hunt D; Jones-Wallace D; Crolla J; Perry R; Lunec J; Pearson A; Ellison D
Br J Cancer; 2001 Sep; 85(5):705-12. PubMed ID: 11531256
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of c-Met expression in glioblastomas.
Kong DS; Song SY; Kim DH; Joo KM; Yoo JS; Koh JS; Dong SM; Suh YL; Lee JI; Park K; Kim JH; Nam DH
Cancer; 2009 Jan; 115(1):140-8. PubMed ID: 18973197
[TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
[TBL] [Abstract][Full Text] [Related]
35. Medulloblastoma: what is the role of molecular genetics?
Entz-Werle N; Carli ED; Ducassou S; Legrain M; Grill J; Dufour C
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1169-81. PubMed ID: 18588461
[TBL] [Abstract][Full Text] [Related]
36. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
37. C-myc expression in the microvessels of medulloblastoma.
Stanić G; Cupić H; Zarković K; Tomas D; Kruslin B
Coll Antropol; 2011 Mar; 35(1):39-42. PubMed ID: 21667531
[TBL] [Abstract][Full Text] [Related]
38. Childhood medulloblastoma.
Massimino M; Giangaspero F; Garrè ML; Gandola L; Poggi G; Biassoni V; Gatta G; Rutkowski S
Crit Rev Oncol Hematol; 2011 Jul; 79(1):65-83. PubMed ID: 21129995
[TBL] [Abstract][Full Text] [Related]
39. Expression of GAS7 in childhood CNS tumors.
Ebinger M; Senf L; Wachowski O; Scheurlen W
Pediatr Blood Cancer; 2006 Mar; 46(3):325-8. PubMed ID: 16078223
[TBL] [Abstract][Full Text] [Related]
40. Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.
Zou C; Smith KD; Liu J; Lahat G; Myers S; Wang WL; Zhang W; McCutcheon IE; Slopis JM; Lazar AJ; Pollock RE; Lev D
Ann Surg; 2009 Jun; 249(6):1014-22. PubMed ID: 19474676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]